Journey Medical (DERM) Free Cash Flow (2020 - 2026)

Journey Medical's Free Cash Flow history runs 7 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• Quarterly Free Cash Flow rose 202.72% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.7 million (up 3.46% YoY) and the FY2025 annual result came in at -$12.4 million, up 48.44% from the prior year.
• Free Cash Flow was $2.9 million for Q1 2026 at Journey Medical, up from -$6.3 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $18.7 million in Q3 2023 and bottomed at -$19.1 million in Q1 2022.
• A 5-year average of -$3.1 million and a median of -$3.3 million in 2022 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow slumped 1504.56% — and 2023, when it soared 357.44%.
• Journey Medical's Free Cash Flow stood at -$3.8 million in 2022, then plunged by 330.66% to -$16.5 million in 2023, then surged by 113.47% to $2.2 million in 2024, then plunged by 382.43% to -$6.3 million in 2025, then jumped by 146.29% to $2.9 million in 2026.
• Business Quant data shows DERM's Free Cash Flow at $2.9 million in Q1 2026, -$6.3 million in Q4 2025, and -$2.4 million in Q3 2025.